Search Results - Michael Ronellenfitsch

  • Showing 1 - 13 results of 13
Refine Results
  1. 1
    The Pan-Bcl-2 Inhibitor (−)-Gossypol Triggers Autophagic Cell Death in Malignant Glioma

    The Pan-Bcl-2 Inhibitor (−)-Gossypol Triggers Autophagic Cell Death in Malignant Glioma by Valerie Voss, Christian Senft, Verena Lang, Michael Ronellenfitsch, Joachim P. Steinbach, Volker Seifert, Donat Kögel

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Synthesis of cytochrome c oxidase 2: a p53-dependent metabolic regulator that promotes respiratory function and protects glioma and colon cancer cells from hypoxia-induced cell death

    Synthesis of cytochrome c oxidase 2: a p53-dependent metabolic regulator that promotes respiratory function and protects glioma and colon cancer cells from hypoxia-induced cell dea... by Christina Wanka, Daniel P. Brucker, Oliver Bähr, Michael Ronellenfitsch, Michael Weller, Joachim P. Steinbach, Johannes Rieger

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Treatment of refractory and superrefractory status epilepticus with topiramate: A cohort study of 106 patients and a review of the literature

    Treatment of refractory and superrefractory status epilepticus with topiramate: A cohort study of 106 patients and a review of the literature by Anne Fechner, Kristina Hubert, Kolja Jahnke, Susanne Knake, Juergen Konczalla, Katja Menzler, Michael Ronellenfitsch, Felix Rosenow, Adam Strzelczyk

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma

    The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma by Martha Foltyn, Anna‐Luisa Luger, Nadja I. Lorenz, Benedikt Sauer, Michel Mittelbronn, Patrick N. Harter, Jörg Steinbach, Michael Ronellenfitsch

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Serine-dependent redox homeostasis regulates glioblastoma cell survival

    Serine-dependent redox homeostasis regulates glioblastoma cell survival by Anna L. Engel, Nadja I. Lorenz, Kevin Klann, Christian Münch, Cornelia Depner, Joachim P. Steinbach, Michael Ronellenfitsch, Anna‐Luisa Luger

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Bevacizumab as a last-line treatment for glioblastoma following failure of radiotherapy, temozolomide and lomustine

    Bevacizumab as a last-line treatment for glioblastoma following failure of radiotherapy, temozolomide and lomustine by Katharina J. Wenger, Marlies Wagner, Se-Jong You, Kea Franz, Patrick N. Harter, Michael C. Burger, Martin Voß, Michael Ronellenfitsch, Emmanouil Fokas, Joachim P. Steinbach, Oliver Bähr

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial

    Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial by Martin Voß, Katharina J. Wenger, Nina von Mettenheim, Jörg Bojunga, Manuela Vetter, Bianca Diehl, Kea Franz, Rüediger Gerlach, Michael Ronellenfitsch, Patrick N. Harter, Elke Hattingen, Joachim P. Steinbach, Claus Rödel, Johannes Rieger

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    The PI3K/Akt/mTOR pathway as a preventive target in melanoma brain metastasis

    The PI3K/Akt/mTOR pathway as a preventive target in melanoma brain metastasis by Cedric Tehranian, Laura Fankhauser, Patrick N. Harter, Colin D.H. Ratcliffe, Pia S. Zeiner, Julia M. Messmer, Dirk C. Hoffmann, Katharina Frey, Dana Westphal, Michael Ronellenfitsch, Erik Sahai, Wolfgang Wick, Matthia A. Karreman, Frank Winkler

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    AMP-activated protein kinase mediates adaptation of glioblastoma cells to conditions of the tumor microenvironment

    AMP-activated protein kinase mediates adaptation of glioblastoma cells to conditions of the tumor microenvironment by Nadja I. Lorenz, Benedikt Sauer, Hans Urban, Jan‐Béla Weinem, Bhavesh S. Parmar, Pia S. Zeiner, Maja Strecker, Dorothea Schulte, Michel Mittelbronn, Tijna Alekseeva, Lisa Sevenich, Patrick N. Harter, Christian Münch, Joachim P. Steinbach, Anna‐Luisa Luger, Dieter Henrik Heiland, Michael Ronellenfitsch

    Published 2025
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases

    Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases by Patrick N. Harter, Simon Bernatz, Alexander Scholz, Pia S. Zeiner, Jenny Zinke, Makoto Kiyose, Stella Blasel, Rudi Beschorner, Christian Senft, Benjamin Bender, Michael Ronellenfitsch, Harriet Wikman, Markus Glatzel, Matthias Meinhardt, Tareq A. Juratli, Jörg Steinbach, Karl H. Plate, Jörg Wischhusen, Benjamin Weide, Michel Mittelbronn

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    PKM2 diverts glycolytic flux in dependence on mitochondrial one-carbon cycle

    PKM2 diverts glycolytic flux in dependence on mitochondrial one-carbon cycle by Mohaned Benzarti, Laura Neises, Anaïs Oudin, Christina Krötz, Elodie Viry, Ernesto Gargiulo, Coralie Pulido, Maryse Schmoetten, Vitaly I. Pozdeev, Nadia I. Lorenz, Michael Ronellenfitsch, David Sumpton, Marc O. Warmoes, Christian Jaeger, Antoine Lesur, Björn Becker, Etienne Moussay, Jérôme Paggetti, Simone P. Niclou, Elisabeth Letellier, Johannes Meiser

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy

    mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy by Markus Weiler, Jonas Blaes, Stefan Pusch, Felix Sahm, Marcus Czabanka, Sebastian Luger, Lukas Bunse, Gergely Solecki, Viktoria Eichwald, Manfred Jugold, Sibylle Hodecker, Matthias Osswald, Christoph Meisner, Thomas Hielscher, Petra Rübmann, P.-N. Pfenning, Michael Ronellenfitsch, Tore Kempf, Martina Schnölzer, Amir Abdollahi, Florian Läng, Martin Bendszus, Andreas von Deimling, Frank Winkler, Michael Weller, Peter Vajkoczy, Michael Platten, Wolfgang Wick

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    The clinical and molecular landscape of diffuse hemispheric glioma, H3 G34-mutant

    The clinical and molecular landscape of diffuse hemispheric glioma, H3 G34-mutant by Émilie Le Rhun, Andrea Bink, Joerg Felsberg, Dorothee Gramatzki, Sebastian Brandner, Jamal Benhamida, Antje Wick, J. C. Tonn, Malte Mohme, Ghazaleh Tabatabai, David Capper, Matija Snuderl, Evangelia Razis, Michael Ronellenfitsch, Nicolas Neidert, Ho‐Keung Ng, Ute Pohl, Tejus Bale, Stefanie Quach, David Rieger, Ulrich Schüller, Julia Onken, Katharina Drüschler, Claude‐Alain Maurage, Luca Regli, Estelle Healy, Maya Srikanth Graham, Tibor Hortobágyi, Simon Paine, Leslie Bridges, Tereza Lausova, Valentina Medici, Philipp Sievers, Daniel Schrimpf, Wolfgang Wick, Felix Sahm, Guido Reifenberger, Andreas von Deimling, Michael Weller

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: